Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 2 |
2020 | 3 |
2025 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program.
Diabetes Obes Metab. 2020 Nov;22(11):2199-2203. doi: 10.1111/dom.14143. Epub 2020 Aug 24.
Diabetes Obes Metab. 2020.
PMID: 32691499
Free PMC article.
Long-Term, Real-World Safety and Efficacy of Teneligliptin: A Post-Marketing Surveillance of More Than 10,000 Patients with Type 2 Diabetes in Japan.
Kadowaki T, Haneda M, Ito H, Sasaki K, Matsukawa M, Yamada Y.
Kadowaki T, et al.
Adv Ther. 2020 Mar;37(3):1065-1086. doi: 10.1007/s12325-019-01189-w. Epub 2019 Dec 23.
Adv Ther. 2020.
PMID: 31873865
Free PMC article.
Item in Clipboard
Favourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study).
Cho KY, Nomoto H, Nakamura A, Kawata S, Sugawara H, Takeuchi J, Nagai S, Tsuchida K, Omori K, Yokoyama H, Manda N, Kurihara Y, Aoki S, Atsumi T, Miyoshi H.
Cho KY, et al.
Diabetes Obes Metab. 2020 Mar;22(3):458-462. doi: 10.1111/dom.13879. Epub 2019 Oct 13.
Diabetes Obes Metab. 2020.
PMID: 31486230
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.